A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies

被引:130
作者
Hahn, K
Arendt, G
Braun, JS
von Giesen, HJ
Husstedt, IW
Maschke, M
Straube, E
Schielke, E
机构
[1] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany
[2] Univ Munster, Dept Neurol, D-4400 Munster, Germany
[3] Univ Duisburg Gesamthsch, Dept Neurol, Essen, Germany
[4] Neurol Clin, Barsinghausen, Germany
[5] Auguste Viktoria Krankenhaus, Dept Neurol, Berlin, Germany
关键词
HIV; gabapentin; neuropathy; neuropathic pain;
D O I
10.1007/s00415-004-0529-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Painful HIV-associated sensory neuropathies (HIV-SN) are a common complication of HIV infection. The pathogenesis is unknown and the treatment very limited. Gabapentin (GBP) is effective in painful diabetic neuropathy and postherpetic neuralgia and its effectiveness on painful HIV-SN has been reported anecdotally. Design Multicenter, prospective, randomised, double-blind, placebo-controlled study. Methods Patients were followed for a 1-week screening, a 4-week double-blind and a 2-week open treatment phase. GBP was initiated at 400 mg/d, titrated over 2 weeks to 1200 mg/d, and then either maintained at this level or - if not beneficial-titrated to 2400 mg/d. After 4 weeks the medication was unblinded and the patient had the choice to begin, to maintain or to increase GBP to 3600 mg/d. The primary outcome measure was an improvement in median pain on the Visual Analogue Scale (VAS) from the screening week compared to the 4(th) treatment week. A secondary efficacy measure was the median sleep score (VAS). Results 15 patients received GBP and 11 placebo. In each group one patient dropped out during the doubleblind phase. Median pain (GBP 5.1; placebo 4.7) and sleep score (GBP 4.5; placebo 5.6) did not differ between both groups at baseline. In the GBP-group there was a significant decrease of the pain to 2.85 (-44.1%) as well as of the sleep VAS to 2.3 (-48.9%). No significant decrease in the pain (median VAS=3.3, -29.8%) as well as in the sleep score (median VAS=4.95, -11.6%) was observed in the placebo-group. GBP was generally well tolerated. The most frequent side effect was somnolence reported in 80% of GBP-treated patients. Conclusions GBP was more effective than placebo in reducing pain and sleep interference in patients with HIV-SN.
引用
收藏
页码:1260 / 1266
页数:7
相关论文
共 27 条
[1]   The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain [J].
Abdi, S ;
Lee, DH ;
Chung, JM .
ANESTHESIA AND ANALGESIA, 1998, 87 (06) :1360-1366
[2]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[3]   Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy [J].
Childs, EA ;
Lyles, RH ;
Selnes, OA ;
Chen, B ;
Miller, EN ;
Cohen, BA ;
Becker, JT ;
Mellors, J ;
McArthur, JC .
NEUROLOGY, 1999, 52 (03) :607-613
[4]  
*DNAA, 2000, NERVENARZT, V71, P442
[5]  
Gatti A, 1998, NEUROLOGY, V50, pA216
[6]  
GRIFFIN JW, 1998, NEUROLOGY AIDS, P275
[7]   EARLY DETECTION OF DISTAL SYMMETRICAL POLYNEUROPATHY DURING HIV-INFECTION BY PAIRED STIMULATION OF SURAL NERVE [J].
HUSSTEDT, IW ;
GROTEMEYER, KH ;
BUSCH, H ;
ZIDEK, W .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1994, 93 (03) :169-174
[8]   HIV-associated sensory neuropathies [J].
Keswani, SC ;
Pardo, CA ;
Cherry, CL ;
Hoke, A ;
McArthur, JC .
AIDS, 2002, 16 (16) :2105-2117
[9]   A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection [J].
Kieburtz, K ;
Simpson, D ;
Yiannoutsos, C ;
Max, MB ;
Hall, CD ;
Ellis, RJ ;
Marra, CM ;
McKendall, R ;
Singer, E ;
Dal Pan, GJ ;
Clifford, DB ;
Tucker, T ;
Cohen, B .
NEUROLOGY, 1998, 51 (06) :1682-1688
[10]   Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations [J].
La Spina, I ;
Porazzi, D ;
Maggiolo, F ;
Bottura, P ;
Suter, F .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (01) :71-75